Healthcare Industry News: vascular access
News Release - September 23, 2011
Scott Solano to Depart AngioDynamicsALBANY, N.Y.--(Healthcare Sales & Marketing Network)-- AngioDynamics (NASDAQ:ANGO ), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced that Scott Solano, Senior Vice President and Chief Technology Officer, has resigned his position effective October 14, 2011, to pursue other interests. Mr. Solano joined AngioDynamics in September 2010.
“We are disappointed that Scott has decided to leave AngioDynamics,” said Joseph DeVivo, President & CEO. “During the past year, Scott contributed significantly to our technology direction and product pipeline. With Scott’s full cooperation, we are implementing an orderly transition of his responsibilities.”
“My decision to leave AngioDynamics is a personal one,” said Mr. Solano. “I believe the Company is well positioned for future growth and wish all of the employees great success in the years ahead.”
AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products, embolization products and venous products. More information is available at www.AngioDynamics.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.